10-Q

United States

Securities and Exchange Commission

Washington, D.C. 20549

Form 10-Q

(Mark One)

þQUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934.

For the quarterly period ended September 30, 2019

or

¨TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934.

For the transition period from _________________ to ______________

Commission File Number: 000-20333

NOCOPI TECHNOLOGIES, INC.

(Exact name of registrant as specified in its charter)

Maryland	87-0406496
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

480 Shoemaker Road, Suite 104, King of Prussia, PA 19406

(Address of principal executive offices) (Zip Code)

(610) 834-9600

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:  None.

Title of each class Trading Symbol(s) Name of each exchange on which registered

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ  No ¨

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes þ  No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer   ¨	Accelerated filer   ¨
Non-accelerated filer     þ	Smaller reporting company  þ
	Emerging growth company  ¨

If an emerging growth company, indicate by checkmark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Securities Act. ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨  No þ

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: 60,324,698 shares of common stock, par value $0.01, as of November 8, 2019.

NOCOPI TECHNOLOGIES, INC.

INDEX

	PAGE
Part I. FINANCIAL INFORMATION
Item 1. Financial Statements	1
Statements of Operations for Three Months and Nine Months Ended September 30, 2019 and September 30, 2018	1
Balance Sheets at September 30, 2019 and December 31, 2018	2
Statements of Cash Flows for Nine Months Ended September 30, 2019 and September 30, 2018	3
Statements of Stockholders’ Equity for Three Months and Nine Months ended September 30, 2019 and September 30, 2018	4
Notes to Financial Statements	5
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations	10
Item 4. Controls and Procedures	15
Part II. OTHER INFORMATION
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
	16
Item 6. Exhibits	16
SIGNATURES	17
EXHIBIT INDEX	18

PART I – FINANCIAL INFORMATION

Item 1. Financial Statements

Nocopi Technologies, Inc.

Statements of Operations*

(unaudited)

	Three Months ended September 30,						Nine Months ended September 30,
	2019			2018			2019			2018
Revenues
Licenses, royalties and fees	$	189,400		$	175,200		$	571,900		$	2,005,700
Product and other sales		448,100			386,200			991,100			854,800
		637,500			561,400			1,563,000			2,860,500
Cost of revenues
Licenses, royalties and fees		41,400			35,100			98,200			84,300
Product and other sales		166,600			137,900			380,300			323,500
		208,000			173,000			478,500			407,800
Gross profit		429,500			388,400			1,084,500			2,452,700
Operating expenses
Research and development		45,200			38,100			122,600			111,300
Sales and marketing		81,000			74,600			224,200			313,200
General and administrative		84,200			73,400			265,200			277,600
		210,400			186,100			612,000			702,100
Net income from operations		219,100			202,300			472,500			1,750,600
Other income (expenses)
Interest income		4,600			700			7,200			1,400
Interest expense and bank charges		(2,600	)		(2,600	)		(8,000	)		(8,300	)
		2,000			(1,900	)		(800	)		(6,900	)
Net income before income taxes		221,100			200,400			471,700			1,743,700
Income taxes		14,300			199,300			30,600			199,300
Net income	$	206,800		$	1,100		$	441,100		$	1,544,400
Basic and diluted net income per common share	$	.00		$	.00		$	.01		$	.03
Weighted average common shares outstanding
Basic		59,614,698			58,616,716			58,949,377			58,616,716
Diluted		59,990,371			59,012,626			59,322,141			58,977,284

*See accompanying notes to these financial statements.

1

Nocopi Technologies, Inc.

Balance Sheets*

	September 30,			December 31,
	2019			2018
	(unaudited)			(audited)
Assets
Current assets
Cash	$	798,000		$	400,800
Accounts receivable less $5,000 allowance for doubtful accounts		834,500			579,000
Inventory		161,000			133,500
Prepaid and other		81,100			43,600
Total current assets		1,874,600			1,156,900
Fixed assets
Leasehold improvements		19,700			19,700
Furniture, fixtures and equipment		185,800			185,400
		205,500			205,100
Less: accumulated depreciation and amortization		198,700			197,600
		6,800			7,500
Other assets
Long-term receivables		1,070,700			1,352,200
Operating lease right of use - building		212,000			–
		1,282,700			1,352,200
Total assets	$	3,164,100		$	2,516,600
Liabilities and Stockholders' Equity
Current liabilities
Convertible debentures	$	97,900		$	128,300
Accounts payable		41,400			16,500
Accrued expenses		202,200			163,000
Income taxes		37,500			38,600
Operating lease liability, current		41,000			–
Total current liabilities		420,000			346,400
Other liabilities
Accrued expenses, non-current		75,000			94,700
Deferred income taxes		47,600			108,800
Operating lease liability, non-current		171,000			–
		293,600			203,500
Stockholders' equity
Common stock, $0.01 par value
Authorized – 75,000,000 shares
Issued and outstanding
2019 – 60,324, 698 shares; 2018 – 58,616,716 shares		603,300			586,200
Paid-in capital		12,465,600			12,440,000
Accumulated deficit		(10,618,400	)		(11,059,500	)
Total stockholders' equity		2,450,500			1,966,700
Total liabilities and stockholders' equity	$	3,164,100		$	2,516,600

*See accompanying notes to these financial statements.

2

Nocopi Technologies, Inc.

Statements of Cash Flows*

(unaudited)

	Nine Months ended September 30,
	2019			2018
Operating Activities
Net income	$	441,100		$	1,544,400
Adjustments to reconcile net income to net cash provided by (used in) operating activities
Depreciation and amortization		2,900			5,300
Deferred income taxes		(61,200	)		106,000
Other assets		69,500			(1,423,800	)
Other liabilities		192,300			99,600
Cumulative effect of accounting change		–			96,100
		644,600			427,600
Increase in assets
Accounts receivable		(255,500	)		(308,000	)
Inventory		(27,500	)		(20,100	)
Prepaid and other		(37,500	)		(8,000	)
Increase (decrease) in liabilities
Accounts payable and accrued expenses		76,400			(159,000	)
Income taxes		(1,100	)		93,300
Deferred revenue		–			(99,400	)
		(245,200	)		(501,200	)
Net cash provided by (used in) operating activities		399,400			(73,600	)
Investment Activities
Additions to fixed assets		(2,200	)		(500	)
Net cash used in investing activities		(2,200	)		(500	)
Increase (decrease) in cash		397,200			(74,100	)
Cash at beginning of year		400,800			360,400
Cash at end of period	$	798,000		$	286,300
Supplemental Disclosure of Non-Cash Investing and Financing Activities
Operating lease right of use – building	$	241,100		$	–
Operating lease liability	$	(241,100	)	$	–
Accumulated depreciation and amortization	$	1,800		$	–
Furniture, fixtures and equipment	$	(1,800	)	$	–
Convertible debentures	$	30,400		$	–
Accrued expenses	$	12,300		$	–
Common stock	$	(17,100	)	$	–
Paid-in capital	$	(25,600	)	$	–

*See accompanying notes to these financial statements.

3

Nocopi Technologies, Inc.

Statements of Stockholders’ Equity*

For the Periods December 31, 2018 through September 30, 2019 and December 31, 2017 through September 30, 2018

(unaudited)

	Common stock				Paid-in		Accumulated
	Shares		Amount		Capital		Deficit			Total
Balance – December 31, 2018		58,616,716	$	586,200	$	12,440,000	$	(11,059,500	)	$	1,966,700
Net income								85,400			85,400
Balance – March 31, 2019		58,616,716		586,200		12,440,000		(10,974,100	)		2,052,100
Net income								148,900			148,900
Balance – June 30, 2019		58,616,716		586,200		12,440,000		(10,825,200	)		2,201,000
Issuance of common stock		1,707,982		17,100		25,600					42,700
Net income								206,800			206,800
Balance – September 30, 2019		60,324,698	$	603,300	$	12,465,600	$	(10,618,400	)	$	2,450,500

	Common stock				Paid-in		Accumulated
	Shares		Amount		Capital		Deficit			Total
Balance – December 31, 2017		58,616,716	$	586,200	$	12,440,000	$	(12,811,000	)	$	215,200
Cumulative effect of accounting change at January 1, 2018, Note 2								96,100			96,100
Net income								95,800			95,800
Balance – March 31, 2018		58,616,716		586,200		12,440,000		(12,619,100	)		407,100
Net income								1,447,500			1,447,500
Balance – June 30, 2018		58,616,716		586,200		12,440,000		(11,171,600	)		1,854,600
Net income								1,100			1,100
Balance – September 30, 2018		58,616,716	$	586,200	$	12,440,000	$	(11,170,500	)	$	1,855,700

* See accompanying notes to these financial statements.

4

NOCOPI TECHNOLOGIES, INC.

NOTES TO FINANCIAL STATEMENTS

(UNAUDITED)

Note 1. Financial Statements

The accompanying unaudited condensed financial statements have been prepared by Nocopi Technologies, Inc. (the “Company”). These statements include all adjustments (consisting only of normal recurring adjustments) which management believes necessary for a fair presentation of the statements and have been prepared on a consistent basis using the accounting policies described in the summary of Accounting Policies included in our Company's 2018 Annual Report on Form 10-K. Certain financial information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations, although our Company believes that the accompanying disclosures are adequate to make the information presented not misleading. The Notes to Financial Statements included in the 2018 Annual Report on Form 10-K should be read in conjunction with the accompanying interim financial statements. The interim operating results for the three and nine months ended September 30, 2019 may not be necessarily indicative of the operating results expected for the full year.

Our Company follows Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 220 in reporting comprehensive income. Comprehensive income is a more inclusive financial reporting methodology that includes disclosure of certain financial information that historically has not been recognized in the calculation of net income. Since our Company has no items of other comprehensive income, comprehensive income is equal to net income.

Note 2. Revenues

On January 1, 2018, our Company adopted ASU 214-09, Revenue from Contracts with Customers (“Topic 606”), using the modified retrospective method. Results for periods beginning on or after January 1, 2018 are presented under Topic 606; however, prior period amounts are not adjusted and continue to be reported in accordance with Topic 605, Revenue Recognition, which was in effect for those periods.

Our Company recorded a decrease to the opening balance of the accumulated deficit of $96,100 and a corresponding charge to deferred revenue as of January 1, 2018 due to the cumulative impact of the adoption of Topic 606. The disclosure of disaggregated revenue is disclosed in Note 10.

The adoption of the new guidance affected our recognition of revenue from licenses and royalties. Under our previous accounting practice, we recognized revenue from licenses and royalties on a straight-line basis over the term of the related license agreement. As a result of our adoption of the new guidance, we will recognize revenue from licensees and royalties at a point in time when the term begins.

During the second quarter of 2018, we negotiated an amendment to a license agreement with a licensee that, in addition to expanding the technologies that the licensee is permitted to market, provides for a four year extension to the license agreement that contains guaranteed royalties payable in installments over the term of the amendment to the license agreement. Since the performance obligation is to grant the license for the use of certain patented ink technology as it exists at the time that it is granted, the promise to grant the license is a performance obligation satisfied at a point in time in accordance with Topic 606. In accordance with Topic 606, we recorded $1,521,700 net of imputed interest of licenses, royalties and fees and $106,500 of selling expenses in the first nine months of 2018 related to the amendment to the license agreement. The related receivable and payable are recorded as other assets and other liabilities on the balance sheet.

The change in accumulated deficit on our Balance Sheet at September 30, 2018, including the aggregate impact of the change in accounting principles which was effective on January 1, 2018, was as follows:

Accumulated deficit – January 1, 2018	$	(12,811,000	)
Net earnings		1,544,400
Cumulative effect of accounting change at January 1, 2018		96,100
Accumulated deficit – September 30, 2018	$	(11,170,500	)

5

NOCOPI TECHNOLOGIES, INC.

NOTES TO FINANCIAL STATEMENTS

(UNAUDITED)

Note 3. Stock Based Compensation

Our Company follows FASB ASC 718, Compensation – Stock Compensation, and uses the Black-Scholes option pricing model to calculate the grant-date fair value of an award. At September 30, 2019, our Company did not have an active stock option plan. There was no unrecognized portion of expense related to stock option grants at September 30, 2019.

Note 4. Line of Credit

In November 2018, our Company negotiated a $150,000 revolving line of credit with a bank to provide a source of working capital, if required. The line of credit is secured by all the assets of our Company and bears interest at the bank’s prime rate for a period of one year and its prime rate plus 1.5% thereafter. The line of credit is subject to an annual review and quiet period. There have been no borrowings under the line of credit since its inception.

Note 5. Convertible Debentures

At September 30, 2019, our Company had convertible debentures totaling $97,900 outstanding, which are due during the third quarter of 2020. The convertible debentures bear interest at 7%. During the third quarter of 2019, our Company’s Board of Directors approved and the holders of $97,900 of the $128,300 of convertible debentures previously outstanding agreed to extend the maturity dates of those convertible debentures for one year to the third quarter of 2020 with no change in the terms or conditions of the debentures. At the option of the lender, the debentures and accrued interest are convertible in whole or part into common stock of our Company at $0.025 per share. During the third quarter of 2019, the holders of approximately $30,400 of previously outstanding convertible debentures elected to convert those debentures plus approximately $12,300 of accrued interest into 1,707,982 shares of restricted stock of our Company.

Our Company also granted warrants in earlier periods to purchase 691,365 shares of our Company’s common stock at $0.02 per share to the holders of the debentures. The warrants are exercisable two years after issuance and expire seven years after issuance. The fair value of the warrants was determined using the Black-Scholes pricing model. The relative fair value of the warrants was recorded as a discount to the notes payable with an offsetting credit to additional paid-in capital since our Company determined that the warrants were an equity instrument in accordance with FASB ASC 815. The debt discount related to the warrant issuances has been accreted through interest expense over the term of the notes payable.

The following table summarizes our Company’s warrant position at September 30, 2019 and December 31, 2018:

					Weighted Average
	Number		Exercise		Exercise
	of Shares		Price		Price
Outstanding warrants -
December 31, 2018		691,365	$	0.02	$	0.02
Outstanding warrants -
September 30, 2019		691,365	$	0.02	$	0.02
Weighted average remaining
contractual life (years)		1.08
Exercisable warrants -
September 30, 2019		691,365	$	0.02	$	0.02

The aggregate intrinsic value of warrants outstanding and exercisable as of September 30, 2019 was approximately $12,100. The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying warrants and the closing stock price of $0.0375 for our Company’s common stock on September 30, 2019.

6

NOCOPI TECHNOLOGIES, INC.

NOTES TO FINANCIAL STATEMENTS

(UNAUDITED)

Note 6. Other Income (Expenses)

Other income (expenses) for the three and nine months ended September 30, 2019 and 2018 includes interest on convertible debentures held by nine investors and interest earned on invested funds.

Note 7. Income Taxes

There is no provision for federal income taxes for the three and nine months ended September 30, 2019 and September 30, 2018 due to the availability of net operating loss carryforwards. Our Company has established a valuation allowance for the entire amount of benefits resulting from our Company’s net operating loss carryforwards because our Company has determined that the realization of the net deferred tax asset is not assured.

The components for state income tax expense resulting from the limitation on the use of net operating losses are:

	Three months ended					Nine months ended
	September 30,					September 30,
	2019			2018		2019			2018
Current state taxes	$	21,100		$	93,300	$	91,800		$	93,300
Deferred state taxes		(6,800	)		106,000		(61,200	)		106,000
	$	14,300		$	199,300	$	30,600		$	199,300

There was no change in unrecognized tax benefits during the period ended September 30, 2019 and there was no accrual for uncertain tax positions as of September 30, 2019.

Tax years from 2016 through 2018 remain subject to examination by U.S. federal and state jurisdictions.

Note 8. Related Party Transactions

During the nine months ended September 30, 2018, our Company paid $235,400 to Michael A. Feinstein, M.D., our Company’s Chairman of the Board and Chief Executive Officer, representing the balance of previously deferred salary owed to him under an employment agreement with our Company. During the five month period ended May 31, 2018, Dr. Feinstein deferred $35,400 of salary. The deferred salary was fully repaid to Dr. Feinstein during 2018 and, at September 30, 2018, there was no remaining deferred salary owed to him. There was no interest payable on the deferred salary.

Note 9. Earnings per Share

In accordance with FASB ASC 260, Earnings per Share, basic earnings per common share is computed using net earnings divided by the weighted average number of common shares outstanding for the periods presented. The computation of diluted earnings per common share involves the assumption that outstanding common shares are increased by shares issuable upon exercise of those warrants for which the market price exceeds the exercise price. The number of shares issuable upon the exercise of such warrants is decreased by shares that could have been purchased by our Company with related proceeds. For the three and nine months ended September 30, 2019, the number of incremental common shares resulting from the assumed conversion of warrants was 375,673 and 372,764, respectively. For the three and nine months ended September 30, 2018, the number of incremental common shares resulting from the assumed conversion of warrants was 395,910 and 360,568, respectively.

7

NOCOPI TECHNOLOGIES, INC.

NOTES TO FINANCIAL STATEMENTS

(UNAUDITED)

Note 10. Major Customer and Geographic Information

Our Company’s revenues, expressed as a percentage of total revenues, from non-affiliated customers that equaled 10% or more of our Company’s total revenues were:

	Three Months ended September 30,						Nine Months ended September 30,
	2019			2018			2019			2018
Customer A		65	%		49	%		47	%		20	%
Customer B		14	%		22	%		21	%		64	%
Customer C		–			11	%		6	%		6	%

Our Company’s non-affiliate customers whose individual balances amounted to more than 10% of our Company’s net accounts receivable, expressed as a percentage of net accounts receivable, were:

	September 30,			December 31,
	2019			2018
Customer A		13	%		6	%
Customer B		79	%		86	%

Our Company performs ongoing credit evaluations of its customers and generally does not require collateral. Our Company also maintains allowances for potential credit losses. The loss of a major customer could have a material adverse effect on our Company’s business operations and financial condition.

Our Company’s revenues by geographic region are as follows:

	Three Months ended September 30,				Nine Months ended September 30,
	2019		2018		2019		2018
North America	$	190,600	$	208,400	$	633,000	$	2,067,700
South America		–		–		–		1,500
Europe		–		100		100		200
Asia		418,300		352,900		901,300		791,100
Australia		28,600		–		28,600		–
	$	637,500	$	561,400	$	1,563,000	$	2,860,500

Note 11. Leases

Our Company conducts its operations in leased facilities under a non-cancelable operating lease expiring in 2024.

Due to the adoption of the new lease standard under the optional transition method which allows the entity to apply the new lease standard at the adoption date, our Company has capitalized the present value of the minimum lease payments commencing January 1, 2019, using an estimated incremental borrowing rate of 6%. The minimum lease payments do not include common area annual expenses which are considered to be non-lease components.

As of January 1, 2019 the operating lease right-of-use asset and operating lease liability amounted to $241,100 with no cumulative-effect adjustment to the opening balance of accumulated deficit.

There are no other material operating leases. Our Company has elected not to recognize right-of-use assets and lease liabilities arising from short-term leases.

Future minimum lease payments under non-cancelable operating leases with initial or remaining terms of one year or more at September 30, 2019 are: $12,600 – 2019; $51,600  – 2020; $53,100 – 2021; $54,600 – 2022; $56,200 – 2023 and $18,900 – 2024.

8

NOCOPI TECHNOLOGIES, INC.

NOTES TO FINANCIAL STATEMENTS

(UNAUDITED)

Total lease expense under operating leases for the three and nine months ended September 30, 2019 was $13,300 and $40,000, respectively. Total lease expense under operating leases for the three and nine months ended September 30, 2018 was $11,300 and $33,800, respectively.

Maturities of lease liabilities are as follows:

	Operating Leases
Year ending December 31
2019	$	12,600
2020		51,600
2021		53,100
2022		54,600
2023		56,200
2024		18,900
Total lease payments		247,000
Less imputed interest		(35,000	)
Total	$	212,000

9

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Forward-Looking Information

This report on Form 10-Q contains, and our officers and representatives may from time to time make, "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as: "anticipate," "intend," "plan," "goal," "seek," "believe," "project," "estimate," "expect," "strategy," "future," "likely," "may," "should," "will" and similar references to future periods. Examples of forward-looking statements include, among others, statements we make regarding:

· Expected operating results, such as revenue growth and earnings

· Anticipated levels of capital expenditures for fiscal year 2019 and beyond

· Current or future volatility in market conditions

· Our belief that we have sufficient liquidity to fund our business operations during the next twelve months

· Strategy for customer retention, growth, product development, market position, financial results and reserves

· Strategy for risk management

Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following:

· The extent to which we are successful in gaining new long-term relationships with customers or retaining significant existing customers and the level of service failures that could lead customers to use competitors' services.

· Our ability to improve our current credit rating with our vendors and the impact on our raw materials and other costs and competitive position of doing so.

· The impact of losing our intellectual property protections or the loss in value of our intellectual property.

· Changes in customer demand.

· The adequacy of our cash flow and earnings and other conditions which may affect our ability to timely service our debt obligations.

· The occurrence of hostilities, political instability or catastrophic events.

· Such other factors as discussed throughout Part I, Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations in this report, and throughout Part II, Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations and in Part I, Item 1A. Risk Factors of our Annual Report on Form 10-K for the year ended December 31, 2018.

Any forward-looking statement made by us in this report is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.

The following discussion and analysis should be read in conjunction with our Condensed financial statements, included herewith. This discussion should not be construed to imply that the results discussed herein will necessarily continue into the future, or that any conclusion reached herein will necessarily be indicative of actual operating results in the future. Such discussion represents only the best present assessment of our management. This information should also be read in conjunction with our audited historical financial statements which are included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2018, filed with the Securities and Exchange Commission on March 29, 2019.

10

Background Overview

Nocopi Technologies, Inc. develops and markets specialty reactive inks for applications in the large educational and toy products market. We also develop and market technologies for document and product authentication, which we believe can reduce losses caused by fraudulent document reproduction or by product counterfeiting and/or diversion. We derive our revenues primarily from licensing our technologies on an exclusive or non-exclusive basis to licensees who incorporate our technologies into their product offering and from selling products incorporating our technologies to the licensees or to their licensed printers.

Unless the context otherwise requires, all references to the “Company,” “we,” “our” or “us” and other similar terms means Nocopi Technologies, Inc., a Maryland corporation.

Results of Operations

Our Company’s revenues are derived from (a) royalties paid by licensees of our technologies, (b) fees for the provision of technical services to licensees and (c) from the direct sale of (i) products incorporating our technologies, such as inks, security paper and pressure sensitive labels, and (ii) equipment used to support the application of our technologies, such as ink-jet printing systems. Royalties consist of guaranteed minimum royalties payable by our licensees in certain cases and additional royalties which typically vary with the licensee’s sales or production of products incorporating the licensed technology. Service fees and sales revenues vary directly with the number of units of service or product provided.

Our Company recognizes revenue on its lines of business as follows:

a.	License fees for the use of our technology and royalties with guaranteed minimum amounts are recognized at a point in time when the term begins;
b.	Product sales are recognized at the time of the transfer of goods to customers at an amount that our Company expects to be entitled to in exchange for these goods, which is at the time of shipment; and
c.	Fees for technical services are recognized at the time of the transfer of services to customers at an amount that our Company expects to be entitled to in exchange for the services, which is when the service has been rendered.

We believe that, as fixed cost reductions beyond those we have achieved in recent years may not be achievable, our operating results are substantially dependent on revenue levels. Because revenues derived from licenses and royalties carry a much higher gross profit margin than other revenues, operating results are also substantially affected by changes in revenue mix.

Both the absolute amount of our Company’s revenues and the mix among the various sources of revenue are subject to substantial fluctuation. We have a relatively small number of substantial customers rather than a large number of small customers. Accordingly, changes in the revenue received from a significant customer can have a substantial effect on our Company’s total revenue, revenue mix and overall financial performance. Such changes may result from a substantial customer’s product development delays, engineering changes, changes in product marketing strategies, production requirements and the like. In addition, certain customers have, from time to time, sought to renegotiate certain provisions of their license agreements and, when our Company agrees to revise such terms, revenues from the customer may be affected.

Revenues for the third quarter of 2019 were $637,500 compared to $561,400 in the third quarter of 2018, an increase of $76,100, or approximately 14%. Licenses, royalties and fees increased by $14,200, or approximately 8%, to $189,400 in the third quarter of 2019 from $175,200 in the third quarter of 2018. The increase in licenses, royalties and fees in the third quarter of 2019 compared to the third quarter of 2018 is due primarily to higher royalties from five licensees offset in part by lower guaranteed licensing revenue of approximately $100,000 in the third quarter of 2019 from one licensee in the entertainment and toy products market as a result of the adoption of ASU 214-09, Revenue from Contracts with Customers (see below) in the second quarter of 2018. We cannot assure you that we will continue to obtain higher royalties on an ongoing basis from licensees in the entertainment and toy products market, especially upon the occurrence of an economic downturn or other unfavorable conditions.

11

Product and other sales increased by $61,900, or approximately 16%, to $448,100 in the third quarter of 2019 from $386,200 in the third quarter of 2018. Sales of ink increased in the third quarter of 2019 compared to the third quarter of 2018 due primarily to higher ink shipments to a third party authorized printer used by one of our Company’s major licensees in the entertainment and toy products market offset in part by lower ink shipments to our Company’s licensees in the retail receipt and document fraud market. In the third quarter of 2019, our Company derived revenues of approximately $555,900 from our licensees and their authorized printers in the entertainment and toy products market compared to revenues of approximately $485,700 in the third quarter of 2018.

For the first nine months of 2019, revenues were $1,563,000, representing a decrease of $1,297,500, or approximately 45%, from revenues of $2,860,500 in the first nine months of 2018. Revenues in the first nine months of 2018 included, in accordance with ASU 214-09, Revenue from Contracts with Customers (“Topic 606”), revenue of $1,521,700 representing the present value of guaranteed royalty payments that are payable over a four-year period beginning in the third quarter of 2019 as a result of an amendment to a license agreement with a licensee that, in addition to expanding the technologies that our licensee is permitted to market, provides for a four year extension to the license agreement beginning in July 2019. Since the performance obligation is to grant the license for the use of certain patented ink technology as it exists at the time that it is granted, the promise to grant the license is a performance obligation satisfied at a point in time in accordance with Topic 606. Previously, we recognized revenue from licenses and royalties on a straight-line basis over the term of the related license agreement. Licenses, royalties and fees decreased by $1,433,800, or approximately 71%, to $571,900 in the first nine months of 2019 from $2,005,700 in the first nine months of 2018. The decrease in licenses, royalties and fees in the first nine months of 2019 compared to the first nine months of 2018 is due primarily to the adoption of Topic 606 described above. See “Plan of Operation, Liquidity and Capital Resources” and “Note 2 to our Condensed Financial Statements” for comparative information on the impact of the adoption of Topic 606 to our Company’s condensed financial statements.

Product and other sales increased by $136,300, or approximately 16%, to $991,100 in the first nine months of 2019 from $854,800 in the first nine months of 2018. Sales of ink increased in the nine months of 2019 compared to the first nine of 2018 due primarily to higher ink shipments to the third party authorized printer used by one of our Company’s major licensees in the entertainment and toy products market and higher ink shipments to our Company’s licensees in the retail receipt and document fraud market. Our Company derived revenues of approximately $1,327,900 from licensees and their authorized printers in the entertainment and toy products market in the first nine months of 2019 compared to revenues of approximately $2,661,700 in the first nine months of 2018. The decrease in revenues from our licensees and their authorized printers in the entertainment and toy products market in the first nine months of 2019 compared to the first nine months of 2018 is due primarily to the adoption of Topic 606.

Our Company’s gross profit increased to $429,500 in the third quarter of 2019, or approximately 67% of revenues, from $388,400 in the third quarter of 2018 or approximately 69% of revenues. Licenses, royalties and fees have historically carried a higher gross profit than product and other sales. Such other sales generally consist of supplies or other manufactured products which incorporate our Company’s technologies or equipment used to support the application of its technologies. These items (except for inks which are manufactured by our Company) are generally purchased from third-party vendors and resold to the end-user or licensee and carry a lower gross profit than licenses, royalties and fees. The higher gross profit in the third quarter of 2019 compared to the third quarter of 2018 results primarily from higher gross revenues from licenses, royalties and fees and product and other sales in the third quarter of 2019 compared to the third quarter of 2018.

For the first nine months of 2019, gross profit was $1,084,500, or approximately 69% of revenues, compared to $2,452,700, or approximately 86% of revenues in 2018. The lower gross profit in the first nine months of 2019 compared to the first nine months of 2018 results primarily from lower licenses, royalties and fees due to the adoption of Topic 606 in 2018 offset in part by higher gross revenues from product and other sales in the first nine months of 2019 compared to the first nine months of 2018.

12

As the variable component of cost of revenues related to licenses, royalties and fees is a low percentage of these revenues and the fixed component is not substantial, period to period changes in revenues from licenses, royalties and fees can significantly affect both the gross profit from licenses, royalties and fees as well as overall gross profit. The gross profit from licenses, royalties and fees decreased to approximately 78% in the third quarter of 2019 compared to approximately 80% in the third quarter of 2018 and to approximately 83% of revenues from licenses, royalties and fees in the first nine months of 2019 from approximately 96% in the first nine months of 2018.

The gross profit, expressed as a percentage of revenues, of product and other sales is dependent on both the overall sales volumes of product and other sales and on the mix of the specific goods produced and/or sold. The gross profit from product and other sales decreased to approximately 63% of revenues in the third quarter of 2019 compared to approximately 64% of revenues in the third quarter of 2018. For the first nine months of 2019 and 2018, the gross profit, expressed as a percentage of revenues, was approximately 62% of revenues from product and other sales.

Research and development expenses of $45,200 and $122,600 in the third quarter and first nine months of 2019, respectively, were comparable to $38,100 and $111,300 in the third quarter and first nine months of 2018, respectively.

Sales and marketing expenses increased in the third quarter of 2019 to $81,000 from $74,600 in the third quarter of 2018. Sales and marketing expenses decreased in the first nine months of 2019 to $224,200 from $313,200 in the first nine months of 2018. The increase in the third quarter of 2019 compared to the third quarter of 2018 is due primarily to higher commission expense on the higher level of revenues in the third quarter of 2019 compared to the third quarter of 2018. The decrease in the first nine months of 2019 compared to the first nine months of 2018 is due primarily to lower commission expense on the lower level of sales in the first nine months of 2019 compared to the first nine months of 2018 related to the additional revenue generated in 2018 as a result of the adoption of Topic 606 in the second quarter of 2018.

General and administrative expenses increased in the third quarter of 2019 to $84,200 from $73,400 in the third quarter of 2018. General and administrative expenses decreased in the first nine months of 2019 to $265,200 from $277,600 in the first nine months of 2018. The increase in third quarter of 2019 compared to the third quarter of 2018 is due primarily to higher employment and public company expenses in the third quarter of 2019 compared to the third quarter of 2018. The decrease in the first nine months of 2019 compared to the first nine months of 2018 is due primarily to lower patent related expenses and lower legal expenses in the first nine months of 2019 compared to the first nine months of 2018.

Other income (expenses) in the third quarter and first nine months of 2019 and 2018 included interest on convertible debentures held by nine investors and interest earned on invested funds.

Income taxes in the third quarter and first nine months of 2019 and 2018 resulted from limitations placed on income tax net operating loss deductions by the Commonwealth of Pennsylvania.

The net income of $206,800 in the third quarter of 2018 compared to net income of $1,100 in the third quarter of 2018 resulted primarily from higher gross profit on a higher level of revenues and lower Pennsylvania income taxes in the third quarter of 2019 compared to the third quarter of 2018 offset in part by higher overhead expenses in the third quarter of 2019 compared to the third quarter of 2018. The net income of $441,100 in the first nine months of 2019 compared to net income of $1,544,400 in the first nine months of 2018 resulted primarily from a lower gross profit on a lower level of revenues in the first nine months of 2019 compared to the first nine months of 2018 related to the adoption of Topic 606 in the second quarter of 2018 offset in part by lower overhead expenses and lower Pennsylvania income taxes in the first nine months of 2019 compared to the first nine months of 2018.

Plan of Operation, Liquidity and Capital Resources

During the first nine months of 2019, our Company’s cash increased to $798,000 at September 30, 2019 from $400,800 at December 31, 2018. During the first nine months of 2018, our Company generated $399,400 from its operating activities and used $2,200 for capital equipment purchases.

In the first nine months of 2019, our Company’s revenues decreased approximately 45% to $1,563,000 from $2,860,500 in the first nine months of 2018 of which an increase of 17%, or $224,200, is attributable to an increase in revenues from historical operations in the first nine months of 2019 compared to the first nine months of 2018 offset by a decrease of $1,521,700, or 62%, that is attributable the reduction of our Company’s revenues in the first nine months of 2019 compared to the first nine months of 2018 as a result of the adoption of Topic 606 in the second quarter of 2018.

13

Our Company’s total overhead expenses, interest expense and income tax expense decreased in the first nine months of 2019 compared to the first nine months of 2018. As a result of these factors, our Company generated net income of $441,100 in the first nine months of 2019 compared to $1,544,400 in the first nine months of 2018. Our Company had positive operating cash flow of $399,400 during the first nine months of 2019 and at September 30, 2019, had positive working capital of $1,454,600 and stockholders’ equity of $2,450,500. For the full year of 2018, our Company had net income of $1,655,400 and had positive operating cash flow of $40,900. At December 31, 2018, our Company had positive working capital of $810,500 and stockholders’ equity of $1,966,700.

Our Company has $97,900 of convertible debentures outstanding that are due during the third quarter of 2020. During the third quarter of 2019, holders of $97,900 of $128,300 of the convertible debentures previously outstanding agreed to extend the maturity dates of the convertible debentures for one year to the third quarter of 2020 with no change in the terms or conditions of the debentures.

In November 2018, our Company negotiated a $150,000 revolving line of credit (“Line of Credit”) with a bank to provide a source of working capital, if required. The Line of Credit is secured by all the assets of our Company and bears interest at the bank’s prime rate for a period of one year and its prime rate plus 1.5% thereafter. The Line of Credit is subject to an annual review and quiet period. There have been no borrowings under the Line of Credit since its inception. We may need to obtain additional capital in the future to further support the working capital requirements associated with our existing revenue base and to develop new revenue sources. We cannot assure you that we will be successful in obtaining such additional capital, if needed. We continue to maintain a cost containment program including curtailment, where possible, of discretionary research and development and sales and marketing expenses.

Our plan of operation for the twelve months beginning with the date of this quarterly report consists of concentrating available human and financial resources to continue to capitalize on the specific business relationships our Company has developed in the entertainment and toy products market. This includes two licensees that have been marketing products incorporating our Company’s technologies since 2012. These two licensees maintain a significant presence in the entertainment and toy products market and are well known and highly regarded participants in this market. We anticipate that these two licensees will expand their current offerings that incorporate our technologies and will introduce and market new products that will incorporate our technologies available to them under their license agreements with our Company. We will continue to develop various applications for these licensees. We also plan to expand our licensee base in the entertainment and toy market. We currently have additional licensees marketing or developing products incorporating our technologies in certain geographic and niche markets of the overall entertainment and toy products market.

Our Company maintains its presence in the retail loss prevention market and believes that revenue growth in this market can be achieved through increased security ink sales to its licensees in this market. We will continue to adjust our production and technical staff as necessary and, subject to available financial resources, invest in capital equipment needed to support potential growth in ink production requirements beyond our current capacity. Additionally, we will pursue opportunities to market our current technologies in specific security and non-security markets. There can be no assurances that these efforts will enable our Company to generate additional revenues and positive cash flow.

Our Company has received and may seek additional capital, in the form of debt, equity or both, to support our working capital requirements and to provide funding for other business opportunities. We cannot assure you that we will be successful in raising additional capital, or that such additional capital, if obtained, will enable our Company to generate additional revenues and positive cash flow.

As previously stated, we generate a significant portion of our total revenues from licensees in the entertainment and toy products market. These licensees generally sell their products through retail outlets. In the future, such sales may be adversely affected by changes in consumer spending that may occur. If such changes occur, our revenues, results of operations and liquidity may be similarly impacted.

Recently Adopted Accounting Pronouncements

In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842) and subsequent related updates. The core principle of Topic 842 is that a lessee should recognize the assets and liabilities that arise from operating leases. Our Company adopted the standard effective January 1, 2019 under the optional transition method which allows the entity to apply the new lease standard at the adoption date and recognize a cumulative-effect adjustment, if any, to the opening balance of retained earnings in the period of adoption. The standard had a material impact on the balance sheet (see Note 11).

14

Recently Issued Accounting Pronouncements Not Yet Adopted

As of September 30, 2019, there are no recently issued accounting standards not yet adopted which would have a material effect on our Company’s financial statements.

Off-Balance Sheet Arrangements

Our Company does not have any off-balance sheet arrangements.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures. Our Company’s management, with the participation of our Company’s Principal Executive Officer and Principal Financial Officer, evaluated the effectiveness of our Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended) as of September 30, 2019. Based on this evaluation, our Company’s Principal Executive Officer and Principal Financial Officer concluded that, as of September 30, 2019, our Company’s disclosure controls and procedures were effective, in that they provide reasonable assurance that information required to be disclosed by our Company in the reports that it files or submits under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms, and is accumulated and communicated to our Company’s management, including our Company’s Principal Executive Officer and Principal Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

Changes in Internal Control Over Financial Reporting. There were no changes in our internal control over financial reporting during the quarter ended September 30, 2019 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

15

PART II - OTHER INFORMATION

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Date	Security/Value
July 2019	Common Stock – 1,707,982 shares of common stock issued pursuant to exercise of convertible debentures with an exercise price of $0.025 per share.

No underwriters were utilized, and no commissions or fees were paid with respect to any of the above transactions. We relied on Section 4(a)(2) and/or Regulation D of the Securities Act of 1933, as amended, since the transactions did not involve any public offering.

Item 6.Exhibits

The following exhibits are included herein:

Exhibit No.	Description of Exhibit	Location
4.1	Form of Convertible Debenture Purchase Agreement and Exhibits	Incorporated by reference to the Company’s Annual Report on Form 10-K filed on September 11, 2015
4.2	Form of Letter Agreement re: Convertible Debenture Purchase Agreement Election	Filed herewith
31.1	Certification of Chief Executive Officer required by Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.	Filed herewith
31.2	Certification of Chief Financial Officer required by Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.	Filed herewith
32.1	Certifications of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.	Filed herewith
101.INS	XBRL Instance Document	Filed herewith
101.SCH	XBRL Taxonomy Extension Schema	Filed herewith
101.CAL	XBRL Taxonomy Extension Calculation Linkbase	Filed herewith
101.DEF	XBRL Taxonomy Extension Definition Linkbase	Filed herewith
101.LAB	XBRL Taxonomy Extension Label Linkbase	Filed herewith
101.PRE	XBRL Taxonomy Extension Presentation Linkbase	Filed herewith

16

SIGNATURES

Pursuant to the requirement of the Securities Exchange Act of 1934, our Company has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	NOCOPI TECHNOLOGIES, INC.
DATE: November 13, 2019	/s/ Michael A. Feinstein, M.D.
	Michael A. Feinstein, M.D.
	Chairman of the Board, President & Chief Executive Officer
DATE: November 13, 2019	/s/ Rudolph A. Lutterschmidt
	Rudolph A. Lutterschmidt
	Vice President & Chief Financial Officer

17

EXHIBIT INDEX

Exhibit No.	Description of Exhibit	Location
4.1	Form of Convertible Debenture Purchase Agreement and Exhibits	Incorporated by reference to the Company’s Annual Report on Form 10-K filed on September 11, 2015
4.2	Form of Letter Agreement re: Convertible Debenture Purchase Agreement Election	Filed herewith
31.1	Certification of Chief Executive Officer required by Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.	Filed herewith
31.2	Certification of Chief Financial Officer required by Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.	Filed herewith
32.1	Certifications of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.	Filed herewith
101.INS	XBRL Instance Document	Filed herewith
101.SCH	XBRL Taxonomy Extension Schema	Filed herewith
101.CAL	XBRL Taxonomy Extension Calculation Linkbase	Filed herewith
101.DEF	XBRL Taxonomy Extension Definition Linkbase	Filed herewith
101.LAB	XBRL Taxonomy Extension Label Linkbase	Filed herewith
101.PRE	XBRL Taxonomy Extension Presentation Linkbase	Filed herewith

18

EX-4.2

EXHIBIT 4.2

July 29, 2019

Dear           :

In a conference call held on July 16 with a number of Nocopi’s convertible debenture holders, the convertible debenture holders present and I discussed alternatives related to the debentures that are maturing during the third quarter of 2019. There are several options available to you. 1) the debentures and accrued interest can be converted into restricted common stock of the Company at $0.025; 2) the debentures and accrued interest can be redeemed for cash; 3) a portion of the debentures and accrued interest can be converted into restricted common stock of the Company at $0.025 with the balance being redeemed for cash. An alternative not discussed and subject to approval by the Board of Directors is a one year extension of the maturity date of your convertible debenture to the third quarter of 2020 with interest continuing to accrue at 7%. I’m available to discuss the options, (xxx) xxx-xxxx. Feel free to contact Rudy at the office as well, (610) 834-9600. The status of your convertible debenture is listed below. Also attached is a W-9 form which will be required as the interest income, whether paid in cash or converted, may need to be reported on a Form 1099.  

Sincerely,

Michael A. Feinstein

Chairman

Amount of Note:

Current Maturity Date:

Accrued Interest to Current Maturity Date:

Selection:

1)

Conversion of all principal and interest to restricted stock _____

2)

Payment of all principal and interest _____

3)

Conversion of a portion of principal (amount  _______ ) and balance in cash

4)

One year extension of principal and interest _____

Please email your response to me and Rudy at xxxxxx@xxxxxx.com and rudy@nocopi.com or fax to the Company at (610) 834-7777.

EX-31.1

EXHIBIT 31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

I, Michael A. Feinstein, M.D., Chief Executive Officer of Nocopi Technologies, Inc., certify that:

1.

I have reviewed this quarterly report on Form 10-Q of Nocopi Technologies, Inc.;

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 13, 2019

/s/ Michael A. Feinstein, M.D.

Michael A. Feinstein, M.D.

Chief Executive Officer

EX-31.2

EXHIBIT 31.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER

I, Rudolph A. Lutterschmidt, Vice President and Chief Financial Officer of Nocopi Technologies, Inc., certify that:

1.

I have reviewed this quarterly report on Form 10-Q of Nocopi Technologies, Inc.;

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (registrant’s fourth fiscal quarter in the case of annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 13, 2019

/s/ Rudolph A. Lutterschmidt

Rudolph A. Lutterschmidt

Vice President and Chief Financial Officer

EX-32.1

EXHIBIT 32.1

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Nocopi Technologies, Inc.  (the "Company") on Form 10-Q for the Quarter ended September 30, 2019 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), the undersigned, Michael A. Feinstein, M.D., Chief Executive Officer, and Rudolph A. Lutterschmidt, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that;

(1) The Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

November 13, 2019

/s/ Michael A. Feinstein, M.D.

Michael A. Feinstein, M.D.

Principal Executive Officer

/s/ Rudolph A. Lutterschmidt

Rudolph A. Lutterschmidt

Principal Financial Officer

XML

Revenues (Tables)

9 Months Ended

Sep. 30, 2019

Revenue from Contract with Customer [Abstract]

Change in Accumulated Deficit Balance

The change in accumulated deficit on our Balance Sheet at September 30, 2018, including the aggregate impact of the change in accounting principles which was effective on January 1, 2018, was as follows:

Accumulated deficit – January 1, 2018	$	(12,811,000	)
Net earnings		1,544,400
Cumulative effect of accounting change at January 1, 2018		96,100
Accumulated deficit – September 30, 2018	$	(11,170,500	)

XML

Line of Credit

9 Months Ended

Sep. 30, 2019

Line of Credit Facility [Abstract]

Line of Credit

Note 4. Line of Credit

In November 2018, our Company negotiated a $150,000 revolving line of credit with a bank to provide a source of working capital, if required. The line of credit is secured by all the assets of our Company and bears interest at the bank’s prime rate for a period of one year and its prime rate plus 1.5% thereafter. The line of credit is subject to an annual review and quiet period. There have been no borrowings under the line of credit since its inception.

XML

Related Party Transactions

9 Months Ended

Sep. 30, 2019

Related Party Transactions [Abstract]

Related Party Transactions

Note 8. Related Party Transactions

During the nine months ended September 30, 2018, our Company paid $235,400 to Michael A. Feinstein, M.D., our Company’s Chairman of the Board and Chief Executive Officer, representing the balance of previously deferred salary owed to him under an employment agreement with our Company. During the five month period ended May 31, 2018, Dr. Feinstein deferred $35,400 of salary. The deferred salary was fully repaid to Dr. Feinstein during 2018 and, at September 30, 2018, there was no remaining deferred salary owed to him. There was no interest payable on the deferred salary.

XML

Major Customer and Geographic Information (Schedule of Non-affiliated Customers with Accounts Receivable) (Details) - Accounts Receivable [Member]	9 Months Ended	12 Months Ended
	Sep. 30, 2019	Dec. 31, 2018
Customer A [Member]
Concentration Risk [Line Items]
Risk percentage	13.00%	6.00%
Customer B [Member]
Concentration Risk [Line Items]
Risk percentage	79.00%	86.00%

XML

Financial Statements

9 Months Ended

Sep. 30, 2019

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Financial Statements

Note 1. Financial Statements

The accompanying unaudited condensed financial statements have been prepared by Nocopi Technologies, Inc. (the “Company”). These statements include all adjustments (consisting only of normal recurring adjustments) which management believes necessary for a fair presentation of the statements and have been prepared on a consistent basis using the accounting policies described in the summary of Accounting Policies included in our Company's 2018 Annual Report on Form 10-K. Certain financial information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations, although our Company believes that the accompanying disclosures are adequate to make the information presented not misleading. The Notes to Financial Statements included in the 2018 Annual Report on Form 10-K should be read in conjunction with the accompanying interim financial statements. The interim operating results for the three and nine months ended September 30, 2019 may not be necessarily indicative of the operating results expected for the full year.

Our Company follows Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 220 in reporting comprehensive income. Comprehensive income is a more inclusive financial reporting methodology that includes disclosure of certain financial information that historically has not been recognized in the calculation of net income. Since our Company has no items of other comprehensive income, comprehensive income is equal to net income.

XML

Balance Sheets - USD ($)	Sep. 30, 2019	Dec. 31, 2018
Current assets
Cash	$ 798,000	$ 400,800
Accounts receivable less $5,000 allowance for doubtful accounts	834,500	579,000
Inventory	161,000	133,500
Prepaid and other	81,100	43,600
Total current assets	1,874,600	1,156,900
Fixed assets
Leasehold improvements	19,700	19,700
Furniture, fixtures and equipment	185,800	185,400
Fixed assets, gross	205,500	205,100
Less: accumulated depreciation and amortization	198,700	197,600
Total fixed assets	6,800	7,500
Other assets
Long-term receivables	1,070,700	1,352,200
Operating lease right of use - building	212,000
Other assets	1,282,700	1,352,200
Total assets	3,164,100	2,516,600
Current liabilities
Convertible debentures	97,900	128,300
Accounts payable	41,400	16,500
Accrued expenses	202,200	163,000
Income taxes	37,500	38,600
Operating lease liability, current	41,000
Total current liabilities	420,000	346,400
Other liabilities
Accrued expenses, non-current	75,000	94,700
Deferred income taxes	47,600	108,800
Operating lease liability, non-current	171,000
Total other liabilities	293,600	203,500
Stockholders' equity
Common stock, $0.01 par value Authorized - 75,000,000 shares Issued and outstanding - 2019 - 60,324, 698 shares; 2018 - 58,616,716 shares	603,300	586,200
Paid-in capital	12,465,600	12,440,000
Accumulated deficit	(10,618,400)	(11,059,500)
Total stockholders' equity	2,450,500	1,966,700
Total liabilities and stockholders' equity	$ 3,164,100	$ 2,516,600

XML

Leases (Tables)

9 Months Ended

Sep. 30, 2019

Lessee Disclosure [Abstract]

Maturities of Lease Liabilities

Maturities of lease liabilities are as follows:

	Operating Leases
Year ending December 31
2019	$	12,600
2020		51,600
2021		53,100
2022		54,600
2023		56,200
2024		18,900
Total lease payments		247,000
Less imputed interest		(35,000	)
Total	$	212,000

XML

Convertible Debentures (Narrative) (Details) - Convertible Debt [Member]	3 Months Ended
	Sep. 30, 2019 USD ($) $ / shares shares
Debt Instrument [Line Items]
Convertible debt amount outstanding	$ 97,900
Convertible debentures extended for one year	$ 97,900
Debt instrument, interest rate	7.00%
Debt instrument, conversion price per share | $ / shares	$ 0.025
Debt converted	$ 30,400
Interest converted	$ 12,300
Shares issued | shares	1,707,982
Number of shares of common stock that can be purchased through warrants | shares	691,365
Price per share of warrants | $ / shares	$ 0.02
Warrants outstanding intrinsic value	$ 12,100
Warrants exercisable intrinsic value	$ 12,100
Closing stock price | $ / shares	$ 0.0375

XML

Revenues (Details) - USD ($)	3 Months Ended						9 Months Ended
	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Sep. 30, 2019	Sep. 30, 2018	Dec. 31, 2018
Revenue from Contract with Customer [Abstract]
Accumulated deficit			$ (11,059,500)			$ (12,811,000)	$ (11,059,500)	$ (12,811,000)
Net earnings	$ 206,800	$ 148,900	$ 85,400	$ 1,100	$ 1,447,500	95,800	441,100	1,544,400
Cumulative effect of accounting change						$ 96,100		96,100
Accumulated deficit	(10,618,400)			(11,170,500)			(10,618,400)	(11,170,500)
Long-term receivable	$ 1,070,700			$ 1,521,700			$ 1,070,700	1,521,700	$ 1,352,200
Selling expense								$ 106,500

XML

Convertible Debentures (Warrants Activity) (Details) - Warrant [Member] - $ / shares	9 Months Ended
	Sep. 30, 2019	Dec. 31, 2018
Warrants
Warrants outstanding	691,365	691,365
Exercise price	$ 0.02	$ 0.02
Weighted average exercise price	$ 0.02	0.02
Weighted average remaining contractual life	1 year 29 days
Exercisable	691,365
Exercisable weighted average exercise price	$ 0.02	$ 0.02

XML

Convertible Debentures

9 Months Ended

Sep. 30, 2019

Convertible Debt [Abstract]

Convertible Debentures

Note 5. Convertible Debentures

At September 30, 2019, our Company had convertible debentures totaling $97,900 outstanding, which are due during the third quarter of 2020. The convertible debentures bear interest at 7%. During the third quarter of 2019, our Company’s Board of Directors approved and the holders of $97,900 of the $128,300 of convertible debentures previously outstanding agreed to extend the maturity dates of those convertible debentures for one year to the third quarter of 2020 with no change in the terms or conditions of the debentures. At the option of the lender, the debentures and accrued interest are convertible in whole or part into common stock of our Company at $0.025 per share. During the third quarter of 2019, the holders of approximately $30,400 of previously outstanding convertible debentures elected to convert those debentures plus approximately $12,300 of accrued interest into 1,707,982 shares of restricted stock of our Company.

Our Company also granted warrants in earlier periods to purchase 691,365 shares of our Company’s common stock at $0.02 per share to the holders of the debentures. The warrants are exercisable two years after issuance and expire seven years after issuance. The fair value of the warrants was determined using the Black-Scholes pricing model. The relative fair value of the warrants was recorded as a discount to the notes payable with an offsetting credit to additional paid-in capital since our Company determined that the warrants were an equity instrument in accordance with FASB ASC 815. The debt discount related to the warrant issuances has been accreted through interest expense over the term of the notes payable.

The following table summarizes our Company’s warrant position at September 30, 2019 and December 31, 2018:

					Weighted Average
	Number		Exercise		Exercise
	of Shares		Price		Price
Outstanding warrants -
December 31, 2018		691,365	$	0.02	$	0.02
Outstanding warrants -
September 30, 2019		691,365	$	0.02	$	0.02
Weighted average remaining
contractual life (years)		1.08
Exercisable warrants -
September 30, 2019		691,365	$	0.02	$	0.02

The aggregate intrinsic value of warrants outstanding and exercisable as of September 30, 2019 was approximately $12,100. The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying warrants and the closing stock price of $0.0375 for our Company’s common stock on September 30, 2019.

XML

Earnings per Share

9 Months Ended

Sep. 30, 2019

Weighted average common shares outstanding

Earnings per Share

Note 9. Earnings per Share

In accordance with FASB ASC 260, Earnings per Share, basic earnings per common share is computed using net earnings divided by the weighted average number of common shares outstanding for the periods presented. The computation of diluted earnings per common share involves the assumption that outstanding common shares are increased by shares issuable upon exercise of those warrants for which the market price exceeds the exercise price. The number of shares issuable upon the exercise of such warrants is decreased by shares that could have been purchased by our Company with related proceeds. For the three and nine months ended September 30, 2019, the number of incremental common shares resulting from the assumed conversion of warrants was 375,673 and 372,764, respectively. For the three and nine months ended September 30, 2018, the number of incremental common shares resulting from the assumed conversion of warrants was 395,910 and 360,568, respectively.

XML

Convertible Debentures (Tables)

9 Months Ended

Sep. 30, 2019

Convertible Debt [Abstract]

Schedule of Warrants Outstanding

The following table summarizes our Company’s warrant position at September 30, 2019 and December 31, 2018:

					Weighted Average
	Number		Exercise		Exercise
	of Shares		Price		Price
Outstanding warrants -
December 31, 2018		691,365	$	0.02	$	0.02
Outstanding warrants -
September 30, 2019		691,365	$	0.02	$	0.02
Weighted average remaining
contractual life (years)		1.08
Exercisable warrants -
September 30, 2019		691,365	$	0.02	$	0.02

XML

Leases (Maturities of Lease Liabilities) (Details) - USD ($)	Sep. 30, 2019	Jan. 02, 2019
Lessee Disclosure [Abstract]
2019	$ 12,600
2020	51,600
2021	53,100
2022	54,600
2023	56,200
2024	18,900
Total lease payments	247,000
Less imputed interest	(35,000)
Total	$ 212,000	$ 241,100

XML

Major Customer and Geographic Information (Schedule of Revenues from Non-affiliated Customers) (Details) - Revenue [Member]	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Customer A [Member]
Revenue, Major Customer [Line Items]
Risk percentage	65.00%	49.00%	47.00%	20.00%
Customer B [Member]
Revenue, Major Customer [Line Items]
Risk percentage	14.00%	22.00%	21.00%	64.00%
Customer C [Member]
Revenue, Major Customer [Line Items]
Risk percentage		11.00%	6.00%	6.00%

XML

Statements of Stockholders' Equity - USD ($)	Common Stock [Member]	Paid-In Capital [Member]	Accumulated Deficit [Member]	Total
Balance at Dec. 31, 2017	$ 586,200	$ 12,440,000	$ (12,811,000)	$ 215,200
Balance shares at Dec. 31, 2017	58,616,716
Cumulative effect of accounting change			96,100	96,100
Net income			95,800	95,800
Balance at Mar. 31, 2018	$ 586,200	12,440,000	(12,619,100)	407,100
Balance shares at Mar. 31, 2018	58,616,716
Balance at Dec. 31, 2017	$ 586,200	12,440,000	(12,811,000)	215,200
Balance shares at Dec. 31, 2017	58,616,716
Cumulative effect of accounting change				96,100
Net income				1,544,400
Balance at Sep. 30, 2018	$ 586,200	12,440,000	(11,170,500)	1,855,700
Balance shares at Sep. 30, 2018	58,616,716
Balance at Mar. 31, 2018	$ 586,200	12,440,000	(12,619,100)	407,100
Balance shares at Mar. 31, 2018	58,616,716
Net income			1,447,500	1,447,500
Balance at Jun. 30, 2018	$ 586,200	12,440,000	(11,171,600)	1,854,600
Balance shares at Jun. 30, 2018	58,616,716
Net income			1,100	1,100
Balance at Sep. 30, 2018	$ 586,200	12,440,000	(11,170,500)	1,855,700
Balance shares at Sep. 30, 2018	58,616,716
Balance at Dec. 31, 2018	$ 586,200	12,440,000	(11,059,500)	$ 1,966,700
Balance shares at Dec. 31, 2018	58,616,716			58,616,716
Net income			85,400	$ 85,400
Balance at Mar. 31, 2019	$ 586,200	12,440,000	(10,974,100)	2,052,100
Balance shares at Mar. 31, 2019	58,616,716
Balance at Dec. 31, 2018	$ 586,200	12,440,000	(11,059,500)	$ 1,966,700
Balance shares at Dec. 31, 2018	58,616,716			58,616,716
Net income				$ 441,100
Balance at Sep. 30, 2019	$ 603,300	12,465,600	(10,618,400)	$ 2,450,500
Balance shares at Sep. 30, 2019	60,324,698			60,324,698
Balance at Mar. 31, 2019	$ 586,200	12,440,000	(10,974,100)	$ 2,052,100
Balance shares at Mar. 31, 2019	58,616,716
Net income			148,900	148,900
Balance at Jun. 30, 2019	$ 586,200	12,440,000	(10,825,200)	2,201,000
Balance shares at Jun. 30, 2019	58,616,716
Issuance of common stock	$ 17,100	25,600		42,700
Issuance of common stock Shares	1,707,982
Net income			206,800	206,800
Balance at Sep. 30, 2019	$ 603,300	$ 12,465,600	$ (10,618,400)	$ 2,450,500
Balance shares at Sep. 30, 2019	60,324,698			60,324,698

XML

Statements of Operations - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Revenues
Licenses, royalties and fees	$ 189,400	$ 175,200	$ 571,900	$ 2,005,700
Product and other sales	448,100	386,200	991,100	854,800
Total revenues	637,500	561,400	1,563,000	2,860,500
Cost of revenues
Licenses, royalties and fees	41,400	35,100	98,200	84,300
Product and other sales	166,600	137,900	380,300	323,500
Total cost of revenues	208,000	173,000	478,500	407,800
Gross profit	429,500	388,400	1,084,500	2,452,700
Operating expenses
Research and development	45,200	38,100	122,600	111,300
Sales and marketing	81,000	74,600	224,200	313,200
General and administrative	84,200	73,400	265,200	277,600
Total operating expenses	210,400	186,100	612,000	702,100
Net income from operations	219,100	202,300	472,500	1,750,600
Other income (expenses)
Interest income	4,600	700	7,200	1,400
Interest expense and bank charges	(2,600)	(2,600)	(8,000)	(8,300)
Total other income (expenses)	2,000	(1,900)	(800)	(6,900)
Net income before income taxes	221,100	200,400	471,700	1,743,700
Income taxes	14,300	199,300	30,600	199,300
Net income	$ 206,800	$ 1,100	$ 441,100	$ 1,544,400
Basic and diluted net income per common share	$ 0.00	$ 0.00	$ .01	$ 0.03
Weighted average common shares outstanding
Basic	59,614,698	58,616,716	58,949,377	58,616,716
Diluted	59,990,371	59,012,626	59,322,141	58,977,284

XML

Income Taxes (Components for State Income Tax Expense) (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Income Tax Disclosure [Abstract]
Current state taxes	$ 21,100	$ 93,300	$ 91,800	$ 93,300
Deferred state taxes	(6,800)	106,000	(61,200)	106,000
Income tax expense	$ 14,300	$ 199,300	$ 30,600	$ 199,300

XML

Major Customer and Geographic Information (Tables)

9 Months Ended

Sep. 30, 2019

Segment Reporting [Abstract]

Schedule of Revenues from Non-affiliated Customers

Our Company’s revenues, expressed as a percentage of total revenues, from non-affiliated customers that equaled 10% or more of our Company’s total revenues were:

	Three Months ended September 30,						Nine Months ended September 30,
	2019			2018			2019			2018
Customer A		65	%		49	%		47	%		20	%
Customer B		14	%		22	%		21	%		64	%
Customer C		–			11	%		6	%		6	%

Schedule of Non-affiliated Customers with Accounts Receivable More Than 10%

Our Company’s non-affiliate customers whose individual balances amounted to more than 10% of our Company’s net accounts receivable, expressed as a percentage of net accounts receivable, were:

	September 30,			December 31,
	2019			2018
Customer A		13	%		6	%
Customer B		79	%		86	%

Schedule of Revenue by Geographic Region

Our Company’s revenues by geographic region are as follows:

	Three Months ended September 30,				Nine Months ended September 30,
	2019		2018		2019		2018
North America	$	190,600	$	208,400	$	633,000	$	2,067,700
South America		–		–		–		1,500
Europe		–		100		100		200
Asia		418,300		352,900		901,300		791,100
Australia		28,600		–		28,600		–
	$	637,500	$	561,400	$	1,563,000	$	2,860,500

XML

Line of Credit (Details)	9 Months Ended
	Sep. 30, 2019 USD ($)
Line of Credit Facility [Abstract]
Line of credit borrowing capacity	$ 150,000
Interest rate	The line of credit is secured by all the assets of our Company and bears interest at the bank’s prime rate for a period of one year and its prime rate plus 1.5% thereafter.

XML

Major Customer and Geographic Information (Schedule of Revenue by Geographic Region) (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues	$ 637,500	$ 561,400	$ 1,563,000	$ 2,860,500
North America [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues	190,600	208,400	633,000	2,067,700
South America [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues				1,500
Europe [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues		100	100	200
Asia [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues	418,300	352,900	901,300	791,100
Australia [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues	$ 28,600		$ 28,600

XML

Related Party Transactions (Details) - Related Party [Member] - USD ($)	5 Months Ended	9 Months Ended
	May 31, 2018	Sep. 30, 2018	Sep. 30, 2019
Related Party Transaction [Line Items]
Deferred salary paid to related party		$ 235,400
Portion of salary to related party deferred during period	$ 35,400
Deferred salary owed to related party			$ 0

XML

Income Taxes

9 Months Ended

Sep. 30, 2019

Income Tax Disclosure [Abstract]

Income Taxes

Note 7. Income Taxes

There is no provision for federal income taxes for the three and nine months ended September 30, 2019 and September 30, 2018 due to the availability of net operating loss carryforwards. Our Company has established a valuation allowance for the entire amount of benefits resulting from our Company’s net operating loss carryforwards because our Company has determined that the realization of the net deferred tax asset is not assured.

The components for state income tax expense resulting from the limitation on the use of net operating losses are:

	Three months ended					Nine months ended
	September 30,					September 30,
	2019			2018		2019			2018
Current state taxes	$	21,100		$	93,300	$	91,800		$	93,300
Deferred state taxes		(6,800	)		106,000		(61,200	)		106,000
	$	14,300		$	199,300	$	30,600		$	199,300

There was no change in unrecognized tax benefits during the period ended September 30, 2019 and there was no accrual for uncertain tax positions as of September 30, 2019.

Tax years from 2016 through 2018 remain subject to examination by U.S. federal and state jurisdictions.

XML

Leases

9 Months Ended

Sep. 30, 2019

Lessee Disclosure [Abstract]

Leases

Note 11. Leases

Our Company conducts its operations in leased facilities under a non-cancelable operating lease expiring in 2024.

Due to the adoption of the new lease standard under the optional transition method which allows the entity to apply the new lease standard at the adoption date, our Company has capitalized the present value of the minimum lease payments commencing January 1, 2019, using an estimated incremental borrowing rate of 6%. The minimum lease payments do not include common area annual expenses which are considered to be non-lease components.

As of January 1, 2019 the operating lease right-of-use asset and operating lease liability amounted to $241,100 with no cumulative-effect adjustment to the opening balance of accumulated deficit.

There are no other material operating leases. Our Company has elected not to recognize right-of-use assets and lease liabilities arising from short-term leases.

Future minimum lease payments under non-cancelable operating leases with initial or remaining terms of one year or more at September 30, 2019 are: $12,600 – 2019; $51,600  – 2020; $53,100 – 2021; $54,600 – 2022; $56,200 – 2023 and $18,900 – 2024.

Total lease expense under operating leases for the three and nine months ended September 30, 2019 was $13,300 and $40,000, respectively. Total lease expense under operating leases for the three and nine months ended September 30, 2018 was $11,300 and $33,800, respectively.

Maturities of lease liabilities are as follows:

	Operating Leases
Year ending December 31
2019	$	12,600
2020		51,600
2021		53,100
2022		54,600
2023		56,200
2024		18,900
Total lease payments		247,000
Less imputed interest		(35,000	)
Total	$	212,000

XML

Balance Sheets (Parenthetical) - USD ($)	Sep. 30, 2019	Dec. 31, 2018
Statement of Financial Position [Abstract]
Allowance for doubtful accounts	$ 5,000	$ 5,000
Common stock, par value	$ 0.01	$ 0.01
Common stock, shares authorized	75,000,000	75,000,000
Common stock, shares issued	60,324,698	58,616,716
Common stock, shares outstanding	60,324,698	58,616,716

XML

Revenues

9 Months Ended

Sep. 30, 2019

Revenue from Contract with Customer [Abstract]

Revenues

Note 2. Revenues

On January 1, 2018, our Company adopted ASU 214-09, Revenue from Contracts with Customers (“Topic 606”), using the modified retrospective method. Results for periods beginning on or after January 1, 2018 are presented under Topic 606; however, prior period amounts are not adjusted and continue to be reported in accordance with Topic 605, Revenue Recognition, which was in effect for those periods.

Our Company recorded a decrease to the opening balance of the accumulated deficit of $96,100 and a corresponding charge to deferred revenue as of January 1, 2018 due to the cumulative impact of the adoption of Topic 606. The disclosure of disaggregated revenue is disclosed in Note 10.

The adoption of the new guidance affected our recognition of revenue from licenses and royalties. Under our previous accounting practice, we recognized revenue from licenses and royalties on a straight-line basis over the term of the related license agreement. As a result of our adoption of the new guidance, we will recognize revenue from licensees and royalties at a point in time when the term begins.

During the second quarter of 2018, we negotiated an amendment to a license agreement with a licensee that, in addition to expanding the technologies that the licensee is permitted to market, provides for a four year extension to the license agreement that contains guaranteed royalties payable in installments over the term of the amendment to the license agreement. Since the performance obligation is to grant the license for the use of certain patented ink technology as it exists at the time that it is granted, the promise to grant the license is a performance obligation satisfied at a point in time in accordance with Topic 606. In accordance with Topic 606, we recorded $1,521,700 net of imputed interest of licenses, royalties and fees and $106,500 of selling expenses in the first nine months of 2018 related to the amendment to the license agreement. The related receivable and payable are recorded as other assets and other liabilities on the balance sheet.

The change in accumulated deficit on our Balance Sheet at September 30, 2018, including the aggregate impact of the change in accounting principles which was effective on January 1, 2018, was as follows:

Accumulated deficit – January 1, 2018	$	(12,811,000	)
Net earnings		1,544,400
Cumulative effect of accounting change at January 1, 2018		96,100
Accumulated deficit – September 30, 2018	$	(11,170,500	)

XML

Leases (Narrative) (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018	Jan. 02, 2019	Dec. 31, 2018
Lessee Disclosure [Abstract]
2019	$ 12,600		$ 12,600
2020	51,600		51,600
2021	53,100		53,100
2022	54,600		54,600
2023	56,200		56,200
2024	18,900		18,900
Lease expense	$ 13,300	$ 11,300	$ 40,000	$ 33,800
Incremental borrowing rate	6.00%		6.00%
Operating lease right-of-use asset	$ 212,000		$ 212,000		$ 241,100
Operating lease liability	$ 212,000		$ 212,000		$ 241,100

XML

Earnings per Share (Details) - shares	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Weighted average common shares outstanding
Number of incremental common shares resulting from the assumed conversion of warrants	375,673	395,910	372,764	360,568

XML

Other Income (Expenses)

9 Months Ended

Sep. 30, 2019

Other Income and Expenses [Abstract]

Other Income (Expenses)

Note 6. Other Income (Expenses)

Other income (expenses) for the three and nine months ended September 30, 2019 and 2018 includes interest on convertible debentures held by nine investors and interest earned on invested funds.

XML

Major Customer and Geographic Information

9 Months Ended

Sep. 30, 2019

Major Customer and Geographic Information [Abstract]

Major Customer and Geographic Information

Note 10. Major Customer and Geographic Information

Our Company’s revenues, expressed as a percentage of total revenues, from non-affiliated customers that equaled 10% or more of our Company’s total revenues were:

	Three Months ended September 30,						Nine Months ended September 30,
	2019			2018			2019			2018
Customer A		65	%		49	%		47	%		20	%
Customer B		14	%		22	%		21	%		64	%
Customer C		–			11	%		6	%		6	%

Our Company’s non-affiliate customers whose individual balances amounted to more than 10% of our Company’s net accounts receivable, expressed as a percentage of net accounts receivable, were:

	September 30,			December 31,
	2019			2018
Customer A		13	%		6	%
Customer B		79	%		86	%

Our Company performs ongoing credit evaluations of its customers and generally does not require collateral. Our Company also maintains allowances for potential credit losses. The loss of a major customer could have a material adverse effect on our Company’s business operations and financial condition.

Our Company’s revenues by geographic region are as follows:

	Three Months ended September 30,				Nine Months ended September 30,
	2019		2018		2019		2018
North America	$	190,600	$	208,400	$	633,000	$	2,067,700
South America		–		–		–		1,500
Europe		–		100		100		200
Asia		418,300		352,900		901,300		791,100
Australia		28,600		–		28,600		–
	$	637,500	$	561,400	$	1,563,000	$	2,860,500

XML

Stock Based Compensation

9 Months Ended

Sep. 30, 2019

Share-based Payment Arrangement [Abstract]

Stock Based Compensation

Note 3. Stock Based Compensation

Our Company follows FASB ASC 718, Compensation – Stock Compensation, and uses the Black-Scholes option pricing model to calculate the grant-date fair value of an award. At September 30, 2019, our Company did not have an active stock option plan. There was no unrecognized portion of expense related to stock option grants at September 30, 2019.

XML

Statements of Cash Flows - USD ($)	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018
Operating Activities
Net income	$ 441,100	$ 1,544,400
Adjustments to reconcile net income to net cash provided by (used in) operating activities
Depreciation and amortization	2,900	5,300
Deferred income taxes	(61,200)	106,000
Other assets	69,500	(1,423,800)
Other liabilities	192,300	99,600
Cumulative effect of accounting change		96,100
Net income adjusted for non-cash operating activities	644,600	427,600
Increase in assets
Accounts receivable	(255,500)	(308,000)
Inventory	(27,500)	(20,100)
Prepaid and other	(37,500)	(8,000)
Increase (decrease) in liabilities
Accounts payable and accrued expenses	76,400	(159,000)
Income taxes	(1,100)	93,300
Deferred revenue		(99,400)
Total increase in operating capital	(245,200)	(501,200)
Net cash provided by (used in) operating activities	399,400	(73,600)
Investment Activities
Additions to fixed assets	(2,200)	(500)
Net cash used in investing activities	(2,200)	(500)
Increase (decrease) in cash	397,200	(74,100)
Cash at beginning of year	400,800	360,400
Cash at end of period	798,000	286,300
Supplemental Disclosure of Non-Cash Investing and Financing Activities
Operating lease right of use - building	241,100
Operating lease liability	(241,100)
Accumulated depreciation and amortization	1,800
Furniture, fixtures and equipment	(1,800)
Convertible debentures	30,400
Accrued expenses	12,300
Common stock	(17,100)
Paid-in capital	$ (25,600)

XML

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2019	Nov. 08, 2019
Document And Entity Information
Entity Registrant Name	NOCOPI TECHNOLOGIES INC/MD/
Entity Central Index Key	0000888981
Document Type	10-Q
Document Period End Date	Sep. 30, 2019
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		60,324,698
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2019
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Incorporation State Country Name	MD
Entity File Number	000-20333

XML

Income Taxes (Tables)

9 Months Ended

Sep. 30, 2019

Income Tax Disclosure [Abstract]

Components for State Income Tax Expense

The components for state income tax expense resulting from the limitation on the use of net operating losses are:

	Three months ended					Nine months ended
	September 30,					September 30,
	2019			2018		2019			2018
Current state taxes	$	21,100		$	93,300	$	91,800		$	93,300
Deferred state taxes		(6,800	)		106,000		(61,200	)		106,000
	$	14,300		$	199,300	$	30,600		$	199,300

XML

Stock Based Compensation (Details)	Sep. 30, 2019 USD ($)
Share-based Payment Arrangement [Abstract]
Unrecognized portion of expense related to stock option grants	$ 0

XML

Income Taxes (Details) - USD ($)	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018
Income Tax Contingency [Line Items]
Change in unrecognized tax benefits during the period
Accrual for uncertain tax positions
Minimum [Member]
Income Tax Contingency [Line Items]
Tax years open for examination	2016
Maximum [Member]
Income Tax Contingency [Line Items]
Tax years open for examination	2018